Drug Trial Radar · NCT07373535
Understanding Music and Mindfulness Preferences in Psilocybin-Assisted Psychotherapy
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
16
Planned (sponsor's estimate)
Start
Dec 2026
Primary completion
Dec 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- Kyle GreenwayAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 28, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this pilot clinical trial is to learn whether it is feasible to individually tailor psilocybin-assisted psychotherapy (PAP) for people with treatment-resistant depression (TRD) based on their personal preferences. The study also aims to explore whether two different psychotherapy styles, music-centered and mindfulness-centered, influence how people respond to psilocybin treatment. The main questions it aims to answer are: * Is it feasible to conduct a patient-preference randomized trial of psilocybin-assisted psychotherapy? * Does receiving a preferred psychotherapy style improve treatment experiences or outcomes? * How do music-centered and mindfulness-centered PAP approaches compare in their effects on improving mood and well-being? Researchers will compare music-centered PAP to mindfulness-centered PAP to see if aligning psychotherapy with individual preferences is a practical and potentially beneficial approach for improving treatment efficacy and tolerability. Participants will: * Be adults with treatment-resistant depression * Receive two 25 mg psilocybin (PEX010, Filament Health) sessions, spaced four weeks apart * Experience one session with music-centered psychotherapy and one with mindfulness-centered psychotherapy * Before treatment, rate their preference for the two psychotherapy approaches * Be randomly assigned to receive their preferred or non-preferred approach first, followed by the other * Complete preparation and integration sessions before and after each psilocybin session This feasibility trial will also collect information on participants' cultural and personal factors influencing psychotherapy preferences using a modified Cultural Formulation Interview, and explore physiological measures of therapeutic alliance, an important factor in psychotherapy outcomes.
Conditions
- Treatment-Resistant Major Depressive Disorder
Interventions
Psilocybin 25mgDrug
Psilocybin 25mg
Music-centered psilocybin-assisted therapyOther
Psilocybin therapy emphasizing the use of music.
Mindfulness-centered psilocybin-assisted therapyOther
Psilocybin therapy emphasizing the use of guided mindfulness.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Enrollment FeasibilityTime frame: From screening through enrollment
- Overall Trial Completion FeasibilityTime frame: From enrollment through the end of active treatment (Week 10)
- Trial Completion by Preference AssignmentTime frame: From enrollment through the end of active treatment (Week 10)
- Distribution of Treatment PreferencesTime frame: Baseline
- Ease of Delivering Treatment Approaches as Assessed by the NASA-TLXTime frame: End of each psilocybin treatment session (Week 3, Week 9)
- Theoretical Framework of Acceptability (TFA)Time frame: Baseline, Weeks 3 and 9 (treatment sessions), Week 11 (follow-up)
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Jewish General Hospital
Montreal, Quebec, Canada
Jewish General Hospital
Montreal, Quebec, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.